The DNA integrity of cryopreserved spermatozoa separated for use in assisted reproductive technology is unaffected by the type of cryoprotectant used but is related to the DNA integrity of the fresh separated preparation
To access this article, please choose from the options below
L.K.T. has nothing to disclose. S.D.F. has nothing to disclose. L.S. has nothing to disclose. K.B. has nothing to disclose. J.-A.Z. has nothing to disclose. A.M.C. has nothing to disclose.
This study was fully funded and supported by Dr. Anne Clark, owner and medical director of Fertility First, as part of Ms. Thomson's Ph.D. studentship.
PII: S0015-0282(08)03273-1
doi:10.1016/j.fertnstert.2008.07.1747
© 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

